Retraction: “Radioimmunotherapy of small‐volume disease of metastatic colorectal cancer: Results of a phase II trial with the iodine‐131–labeled humanized anti–carcinoembryonic antigen antibody hMN‐14,”

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|13|2290-2290

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.13, 2015-07, pp. : 2290-2290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 26, Iss. 1, 2003-03 ,pp. : 44-48

Karger

Access to resources Recommend Favorite

Chemotherapy-Induced Carcinoembryonic Antigen Surge in Patients with Metastatic Colorectal Cancer

By  

Oncology, Vol. 70, Iss. 1, 2006-03 ,pp. : 49-53

Karger

Access to resources Recommend Favorite

Phase II Trial of Oxaliplatin and Tegafur/Uracil and Oral Folinic Acid for Advanced or Metastatic Colorectal Cancer in Elderly Patients

By  

Oncology, Vol. 69, Iss. 2, 2005-09 ,pp. : 122-129

Karger

Access to resources Recommend Favorite

Phase II Trial of Alternating mFOLFOX6 and FOLFIRI Regimens in the First-Line Treatment for Unresectable or Metastatic Colorectal Cancer (KSCC0701)

By  

Oncology, Vol. 84, Iss. 4, 2013-01 ,pp. : 233-239

Karger

Access to resources Recommend Favorite

An Alternating Regimen of Irinotecan/ 5-Fluorouracil/Folinic Acid and Oxaliplatin/ 5-Fluorouracil/Folinic Acid in Metastatic Colorectal Cancer: A Phase II Trial

By  

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 283-289

Karger

Access to resources Recommend Favorite